Biological properties of ten human ovarian carcinoma cell lines: calibration in vitro against four platinum complexes (Q36467555)

14 August 2017

Biological properties of ten human ovarian carcinoma cell lines: calibration in vitro against four platinum complexes (English)

1 reference

14 August 2017

0 references

1 reference

1 reference

Hills CA

1

1 reference

14 August 2017

Kelland LR

2

1 reference

14 August 2017

Abel G

3

1 reference

14 August 2017

Siracky J

4

1 reference

14 August 2017

Wilson AP

5

1 reference

14 August 2017

Harrap KR

6

1 reference

14 August 2017

language of work or name

English

0 references

publication date

1 April 1989

1 reference

British Journal of Cancer

14 August 2017

1 reference

14 August 2017

59

1 reference

14 August 2017

527-534

1 reference

14 August 2017

4

1 reference

describes a project that uses

14 August 2017

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

https://scigraph.springernature.com/pub.10.1038/bjc.1989.108

0 references

cites work

Reactivity of a monoclonal antibody with human ovarian carcinoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2247140

Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2247140

Monoclonal antibody to cytokeratin for use in routine histopathology

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2247140

Phase I studies with carboplatin at the Royal Marsden Hospital

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2247140

A study of some variables in a tetrazolium dye (MTT) based assay for cell growth and chemosensitivity

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2247140

Feasibility of drug screening with panels of human tumor cell lines using a microculture tetrazolium assay

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2247140

In vitro screening of new drugs and analogues--specificity and selectivity

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2247140

One Hundred and Twenty-Seven Cultured Human Tumor Cell Lines Producing Tumors in Nude Mice23

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2247140

Quantitation of differential sensitivity of human-tumor stem cells to anticancer drugs

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2247140

The National Cancer Chemotherapy Program

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2247140

The National Cancer Institute antitumor drug discovery program, current and future perspectives: a commentary.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2247140

Characterization of a human ovarian carcinoma cell line (NIH:OVCAR-3) with androgen and estrogen receptors.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2247140

Characterization of a cell line derived from the ascites of a patient with papillary serous cystadenocarcinoma of the ovary.

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2247140

Cell lines derived from human ovarian carcinomas: growth stimulation by gonadotropic and steroid hormones.

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2247140

Comparative properties of five human ovarian adenocarcinoma cell lines.

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2247140

Ovarian trials at the Royal Marsden.

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2247140

Semiautomated colorimetric assay for in vitro screening of anticancer compounds.

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2247140

Cellular heterogeneity and drug resistance in two ovarian adenocarcinoma cell lines derived from a single patient.

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2247140

cis-Diammine-1, 1-cyclobutane dicarboxylate platinum II (carboplatin) in the treatment of testicular germ-cell tumours: a preliminary report.

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2247140

Characterization of four new cell lines derived from human squamous carcinomas of the uterine cervix.

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2247140

Rationale for development of platinum analogs

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2247140

Comparison of four new cell lines from patients with adenocarcinoma of the ovary

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2247140

1,2-Diaminocyclohexane platinum derivatives of potential clinical value.

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2247140

Synthesis, physical properties, and antitumor activity of tetraplatin and related tetrachloroplatinum(IV) stereoisomers of 1,2-diaminocyclohexane

21 September 2018

1 reference

12 December 2020

Patterns of expression of a tumor associated antigen, defined by the monoclonal antibody HMFG2, in human epithelial ovarian carcinoma. Comparison with expression of the HMFG1, AUA1 and F36/22 antigens

1 reference

12 December 2020

Initial assessment of tumor-associated antigen CA-125 in patients with ovarian, cervical, and testicular tumors

1 reference

12 December 2020

Monoclonal antibodies to epithelium-specific components of the human milk fat globule membrane: Production and reaction with cells in culture

1 reference

12 December 2020

Flow cytometric and morphological studies of ovarian carcinoma cell lines and xenografts

1 reference

12 December 2020

Application of a human tumor colony-forming assay to new drug screening

1 reference

12 December 2020

Preclinical studies identifying carboplatin as a viable cisplatin alternative

1 reference

12 December 2020

Circulating tumor-associated antigen detected by the monoclonal antibody HMFG2 in human epithelial ovarian cancer

1 reference

12 December 2020

Identifiers

DOI

10.1038/BJC.1989.108

1 reference

Dimensions Publication ID

14 August 2017

0 references

1 reference

14 August 2017

1 reference